Vector Borne Diseases
Recent clinical, regulatory, research and industry developments relating to this disease.
Addressing the rise of autochthonous vector-borne diseases in a warming Europe.
The impact of increasing temperatures due to climate change on infectious diseases.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- Active recent publication activity.
- 2 clinical trials with recent milestones (1 completed or reporting results).
Research HighlightsViewHide
Clinical MilestonesViewHide
- 2026-01-10ClinicalAn Open Label Phase I/IIa Clinical Trial to Assess the Safety, Immunogenicity and Efficacy of the Malaria Vaccine Candidate RH5.2-virus-like Particle (VLP) in Matrix-MTM, and to Compare the Safety and Immunogenicity of the Malaria Vaccine Candidates RH5.2-VLP in Matrix-MTM and RH5.1 Soluble Protein in Matrix-MTM Used in Various RegimensPrimary completion
- 2025-12-10ClinicalAn Open Label Phase 1b Study to Characterise the Pharmacokinetic/Pharmacodynamic Relationship and Safety of MMV367 in Healthy Adult Participants Experimentally Infected With Blood Stage Plasmodium FalciparumResults posted
- 2025-09-29ResearchImmunology of vector-borne diseases: the role of immunopharmacology in controlling viral and parasitic infections.Abbasi E · 2025
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Vector Borne Diseases3
- Climate Change2
- Aedes1
- Chikungunya Fever1
- Communicable Diseases1
- Communicable Diseases, Emerging1
- Dengue1
- Disease Vectors1
Leading journals5
- BMC infectious diseases1
- BMJ (Clinical research ed.)1
- Frontiers in public health1
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases1
- PLoS neglected tropical diseases1
Leading researchers8
- Abbasi E1
- Anikeeva O1
- Bi P1
- Borg M1
- Cao LC1
- Chala B1
- Courtenay O1
- Fleischmann WA1
Affiliations (unnormalised)6
- Center for Infectious Diseases1
- Durham University1
- Fujian Medical University1
- Institute of Medical Microbiology and Clinic for Infectious Diseases1
- Institute of Tropical Medicine1
- Liverpool School of Tropical Medicine1
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Vector-borne diseases are infectious diseases transmitted by disease vectors. They include a wide range of illnesses such as malaria, dengue, leishmaniasis, West Nile virus infection, and tick-borne encephalitis. The literature emphasizes that they are a major global public health burden and can emerge or re-emerge in new regions.
These diseases are caused by pathogens transmitted through vectors rather than by direct person-to-person spread. The grounding also links emergence and re-emergence to interactions among pathogens, hosts, and the environment, as well as social and demographic factors such as urbanization, globalization, trade, travel, and close interactions with livestock. Climate change is also supported as a contributor through altered temperature, humidity, rainfall, and vector distribution.
The disease process depends on transmission by vectors and on complex interactions among the pathogen, the vector, and the host immune response. The literature highlights vector saliva, pathogen immune evasion, and host immunomodulation as important biological features. Environmental change can alter vector activity, distribution, and diversity, which in turn affects transmission dynamics.
Supported risk factors include climate change and rising temperatures, which can expand or intensify vector activity and distribution. Social and demographic factors such as urbanization, globalization, trade, travel, population growth, and close contact with livestock are also linked to emergence and re-emergence. The burden is noted to be especially high in socioeconomically disadvantaged regions.
The principal control strategy described in the grounding is vector control, including environmental management and insecticide-based tools. The literature also mentions surveillance, early warning systems, weather-linked predictive models, and robust vector control strategies as important public health measures. Review material additionally notes drug therapy and immunological approaches, including host-directed immunotherapies and monoclonal antibodies, but does not support a single disease-wide drug-class standard of care.
AI-generated summary grounded in MeSH and 5 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Infectious diseases transmitted by DISEASE VECTORS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.